These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9476321)

  • 1. Prenatal diagnosis of trisomy 18 at the 10-14-week ultrasound scan.
    Sherod C; Sebire NJ; Soares W; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):387-90. PubMed ID: 9476321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for fetal anomalies by ultrasound at 14 and 21 weeks.
    D'Ottavio G; Meir YJ; Rustico MA; Pecile V; Fischer-Tamaro L; Conoscenti G; Natale R; Mandruzzato GP
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):375-80. PubMed ID: 9476319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation.
    Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH
    Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
    Snijders RJ; Sebire NJ; Nayar R; Souka A; Nicolaides KH
    Am J Med Genet; 1999 Sep; 86(3):205-7. PubMed ID: 10482866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
    Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trisomy 18: first-trimester nuchal translucency with pathological correlation.
    Jackson S; Porter H; Vyas S
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):55-6. PubMed ID: 7850592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of mosaic trisomy 8 in a fetus with normal nuchal translucency thickness and reversed end-diastolic ductus venosus flow.
    Campbell S; Mavrides E; Prefumo F; Presti F; Carvalho JS
    Ultrasound Obstet Gynecol; 2001 Apr; 17(4):341-3. PubMed ID: 11339193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.
    Hyett JA; Sebire NJ; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Feb; 7(2):101-3. PubMed ID: 8776233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester sonographic findings in trisomy 18: a review of 53 cases.
    Sepulveda W; Wong AE; Dezerega V
    Prenat Diagn; 2010 Mar; 30(3):256-9. PubMed ID: 20112232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
    Noble PL; Abraha HD; Snijders RJ; Sherwood R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):390-5. PubMed ID: 8903913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal exomphalos at 11 to 14 weeks of gestation.
    Snijders RJ; Brizot ML; Faria M; Nicolaides KH
    J Ultrasound Med; 1995 Aug; 14(8):569-74. PubMed ID: 7474053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal sonographic findings in trisomy 13, 18, 21 and 22. A review of 46 cases.
    Seoud MA; Alley DC; Smith DL; Levy DL
    J Reprod Med; 1994 Oct; 39(10):781-7. PubMed ID: 7837124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sonographic features of fetal trisomy 18 at 13 and 14 weeks: four case reports.
    Lam YH; Tang MH
    Ultrasound Obstet Gynecol; 1999 May; 13(5):366-9. PubMed ID: 10380305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy 10: first-trimester features on ultrasound, fetoscopy and postmortem of a case associated with increased nuchal translucency.
    Schwärzler P; Moscoso G; Bernard JP; Hill L; Senat MV; Ville Y
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):67-70. PubMed ID: 10201090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
    Hyett JA; Noble PL; Snijders RJ; Montenegro N; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Apr; 7(4):239-44. PubMed ID: 8726874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.